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Introduction:We aim to investigate the longitudinal associations between changes in
body weight (BW) and declines in cognitive function and risk of mild cognitive impair-
ment (MCI)/dementia among cognitively normal individuals 65 years or older.
Methods: Data from the Age Gene/Environment Susceptibility-Reykjavik Study
(AGES-Reykjavik Study) including 2620 participants, were examined using multiple
logistic regressionmodels. Cognitive function included speedof processing (SP), execu-
tive function (EF), andmemory function (MF). Changes inBWwere classified as;weight
loss (WL), weight gain (WG), and stable weight (SW).
Results:Mean follow-up timewas5.2 years and61.3%were stableweight. Participants
who experiencedWL (13.4%) were significantly more likely to have declines inMF and
SP compared to the SW group. Weight changes were not associated with EF. WL was
associated with a higher risk of MCI, while WG (25.3%) was associated with a higher
dementia risk, when compared to SW.
Discussion: Significant BW changes in older adulthood may indicate impending
changes in cognitive function.
KEYWORDS
APOE ε4, body weight changes, cognitive function, dementia, executive function, memory func-
tion, mild cognitive impairment, nutrition, speed of processing
1 INTRODUCTION
The increase int the aging populations around the world comes with
a burden of neuropsychological disorders including mild cognitive
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any
medium, provided the original work is properly cited, the use is non-commercial and nomodifications or adaptations aremade.
© 2021 The Authors. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring published byWiley Periodicals, LLC on behalf of Alzheimer’s Association
impairment (MCI) and dementia, which are multi-factorial disorders
that are determined by an interplay of environmental factors and
genetic susceptibility.1 Older age remains the strongest risk factor for
dementia, although many modifiable risk factors have been suggested
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RESEARCH INCONTEXT
1. Systematic review: The literaturewas searched using rel-
evant sources such as Google Scholar and PubMed. Iden-
tified papers concerning body weight and changes in cog-
nitive function were cited appropriately.
2. Interpretation: Our study showed that participants who
lost body weight during the follow-up period had lower
cognitive function after follow-up compared to weight-
stable or weight-gaining participants and that conse-
quently these participants had a higher risk of develop-
ing mild cognitive impairment (MCI). Weight gain had an
associationwith increased risk for dementia compared to
weight-stable participants.
3. Future direction: The design of future prevention tri-
als on dementia should consider body weight changes
among older adults as a marker for cognitive changes.
Future intervention studies should address the question
whether keeping body weight stable during older adult-
hood helps to maintain cognitive function and decreases
the risk ofMCI and dementia.
by observational studies2 as estimated to account for at least 30% of
dementia occurrence. These risk factors include a variety of life-style
related factors, for example, physical activity (PA), body mass index
(BMI), and nutrition.1–6
Although prior studies have associated BMI with cognitive func-
tion and dementia, results have been conflicting due to variability
in study design7 and whether BMI is measured in mid-life or late-
life.8,9 Some studies showed that high mid-life BMI is associated with
a risk of developing dementia,9 but conversely, the same is true for
low BMI when measured in late-life.8 However, according to a recent
meta-analysis, current available evidence does not support a clear
association between overweight/obesity and incident dementia in
old age.10
Fewer studies are available on changes in body weight and cogni-
tive functionduring old adulthood. It has been shown thatweight loss is
associated with the risk of dementia11; it has also been suggested that
weight loss is rather a consequenceof thepreclinical phaseof dementia
and this suggests a reverse causation between weight loss and demen-
tia. However, associations between cognitive function and weight loss
as well as weight gain are less clear.
Themechanism relatingweight loss to cognition are not fully under-
stood but recent studies have suggested that apathy, anxiety, depres-
sion, and irritability among dementia and MCI cases affect appetite.12
However, it is also conceivable that weight loss could accelerate brain
atrophy before the onset ofMCI or dementia.11
Weight loss coming from an inadequate dietary intake eventually
leads to deficiency in critical nutrients,13 making nutrition important
in these associations. Another consideration is whether body weight
changes are associated with cognition via known or suggested risk fac-
tors for dementia; for example, vitamin D has been suggested to be
associated with cognitive decline14 as well as apolipoprotein E (APOE)
ε4.15,16
To gain more knowledge on the relation between cognitive func-
tion and body weight, we conducted this analysis based on data
from the longitudinal Age Gene/Environment Susceptibility-Reykjavik
Study (AGES-Reykjavik Study). The aim of this study was to (1) inves-
tigate the longitudinal associations between changes in late-life body
weight and declines in cognitive function and risk of MCI/dementia
in community-dwelling older adults with normal cognitive function at
baseline. Further adding to the novelty of this study, we considered
potential confoundingof physical activity, nutritional factors, andAPOE
ε4 when examining the associations between changes in body weight
and cognitive function.
2 METHODS
2.1 Study population and study design
The current longitudinal analysis is based on data from the AGES-
Reykjavik Study (N = 5764), which examined risk factors for dis-
eases in old age, including environmental factors, genetic susceptibil-
ity, and their interactions. Briefly the AGES-Reykjavik (AGES I) Study
was enrolled in 2002 to 2006 as a continuation of the population-
based Reykjavik Study (RS) in Iceland, initiated in 1967, including men
and women born in 1907 to 1935 and living in the Reykjavik area.17
Detailed baseline information has been described in the AGES study
paper.18 Between 2007 and 2011, all surviving AGES I participants
(58%,N=3316) returned for a5-year follow-upvisit (AGES II). The cur-
rent study included participants who were cognitively normal at base-
line and had relevant follow-up examination including cognitive tests
and BMI. The study was approved by the National Bioethics Commit-
tee in Iceland (approval VSN-00-063), the Data Protection Authority,
and by the National Institute on Aging Intramural Institutional Review
Board.Written informed consent was obtained from all participants.
2.2 Anthropometrics
Weight and height were measured and BMI was calculated as kg/m2.
Participants were categorized as underweight (baseline BMI <18.5),
normalweight (BMI 18.5-24.9), overweight (BMI 25.0-29.9), and obese
(BMI ≥30.0). Using the weight variables (baseline and follow-up), par-
ticipants were further categorized into weight stable, weight gain, and
weight loss if they had lost or gained≥5%weight during follow-up as is
considered clinically relevant weight changes.19
2.3 Cognitive function assessment
Assessment of cognitive function included eight tests, both at baseline
and follow-up, focusing on three cognitive domains, that is, memory,
processing speed, and executive function.
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For each of the domains, a composite score was constructed based
on a theoretical grouping of the tests and by converting raw scores
into standardized z scores reflecting the distribution within the study
sample as previously described.20 The inter-rater reliability for all tests
was excellent (Spearman correlation coefficients range 0.96 to 0.99).21
The memory composite measure included the immediate and delayed-
recall portions of a modified version of the California Verbal Learning
Test.22 The processing speed composite measure included the Digit
Symbol Substitution Test,23 the Figure Comparison Test,24 and the
Stroop Test25 Part I (reading) and Part II (color naming). The executive
function composite measure included the Digits Backward Test23 and
the Stroop Test, Part III (word-color interference). The three domains
of memory, processing speed, and executive function composite mea-
sures were each used as a continuous variable.
2.4 Mild cognitive impairment
The diagnoses of MCI were done by a panel of specialists. The crite-
rion was having deficits in memory or one other domain of cognitive
function or deficits in at least two cognitive domains without being
severe enough to cross the threshold for dementia and without loss of
instrumental activities of daily living. Cognitive performance on a given
domain was evaluated with scoring<−1.5 SD below a cut-point deter-
mined from the distribution of scores in a cohort subsample.19
2.5 Dementia
Assessment of cognitive function was done following a three-step pro-
tocol to identify subjects with dementia. First, the Digit Symbol Substi-
tution test23 and the Mini-Mental State Examination (MMSE)26 were
administered to the total sample. Participants who scored 23 or lower
on the MMSE or had a raw score of 17 or lower on the Digit Symbol
Substitution test were administered a second diagnostic cognitive test
battery. Participantswho scored 8 ormore on Trails B,27 whichwas the
ratio of time taken for “Trails B/Trails A,” or had lower than total score
of 19 for the four immediate recall trials of the Rey Auditory Verbal
Learning28 went on to a third step. This step included a neurological
test and a proxy interview regarding medical history, social, cognitive,
and daily functioning changes of the participant.
A consensus diagnosis of dementia made by a team composed of
a geriatrician, neurologist, neuropsychologist, and a neuroradiologist
was made according to international guidelines from the Diagnostic
and Statistical Manual ofMental Disorders, Fourth Edition.29
2.6 Covariates
2.6.1 Baseline demographic data
Participants were asked about their age, gender, and current marital
status categorized as married, widowed, divorced, or single. Education
was categorized into four levels: primary, secondary, college, and uni-
versity.
2.6.2 Blood pressure
Blood pressure (mm Hg) was measured in a recumbent position using
mercury sphygmomanometer and a large cuff on the right arm (with a
few exceptions) after participants had rested for 5minutes.
2.6.3 Lifestyle and nutritional data
The accredited Icelandic Heart Associations laboratory performed 25-
hydroxy vitamin D (25OHD) measurements in batch using unfrozen
serum samples and the Liaison chemiluminescence immunoassay (Dia-
Sorin Inc, Stillwater, Minnesota). Existing serum 25OHD levels were
then standardized according to the international Vitamin D Standard-
ization Program as described previously.20
Leisure time physical activity (PA) was assessed by a self-reported
questionnaire and categorized into (1) none, (2) ≤3 hours per week, or
(3) > 3 hours per week. Smoking status was evaluated as ever versus
never smoker. Alcohol consumption was evaluated as currently con-
suming versus not consuming.
2.6.4 Medication use and APOE ε4 genotype
Participants were instructed in advance to bring all medication they
had used during the preceding 2 weeks before the clinic visit and were
categorized into ≤4 medications versus ≥5 medications. APOE ε4 alle-
les were genotyped on a subsample of 2113 people using standard
methods.30 The basic characteristics of this subsample did not dif-
fer from those of the remaining sample. Participants were considered
APOE ε4 positive if they carried ε3/4 and ε4/4 genotype; otherwise if
they carried ε2/2, ε2/3, and ε3/3 they were considered APOE ε4 non-
carriers.
2.7 Analytical sample
From the original sample size of 5764 in the provided data base, 3316
participants completed the follow-upmeasurements. Participantswith
anMCI (n=204) or dementia diagnosis (n=47) at baseline and partici-
pants having incompletedata (n=445)wereexcluded fromthepresent
analysis. From the remaining sample, 2620 participants had a complete
data set of relevant variables and were thus included into the present
study.
2.8 Statistical analysis
Statistical analyses were carried out using IBM SPSS version 22.0
(SPSS, Chicago, IL, USA). Demographic, anthropometric, lifestyle and
nutritional data, medication use, and APOE ε4 genotype variables were
used to describe baseline characteristics of the participants (Table 1)
according to body weight change categories. We used the chi-square
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TABLE 1 Demographic and health characteristics according to weight groups among AGES-Reykjavik participants (N= 2620)
Weight loss Weight gain Noweight change
(n= 352, 13.4%) (n= 665, 25.3%) (n= 1603, 61.3%)
Mean± SD Mean± SD Mean± SD P *
Demographic data
Age (years) 75.14± 4.69 73.46± 4.36 74.15± 4.53 <.001
Male (%) 33.4 36.7 43.4 <.001
Female (%) 66.6 63.3 56.6
Education-primary (%) 16.9 22.7 17.1 .161
Married (%) 61.5 57.9 68.5 .001
Lifestyle data
Physical inactivity (%) 33.3 31.2 28 .020
Alcohol-no (%) 30.1 33.1 27.7 .340
Smoke-yes (%) 8.1 11.8 7.3 .026
Anthropometric data
BMI (kg/m2) 27.93± 4.47 26.97± 4.27 27.16± 4.05 <.001
Body fat (%) 30.5± 7.44 29.30± 7.94 28.77± 7.62 <.001
SBP (mmHg) 142.1± 20.51 140.2± 20.11 142.4± 19.14 .171
DBP (mmHg) 73.1± 9.18 74.8± 9.13 74.60± 9.37 .002
Laboratory data
25OHD (nmol/L) 56.01± 16.94 55.39± 18.92 60.13± 17.11 <.001
Neuropsychological data
Memory (z-score) 0.140± 0.882 0.242± 0.888 0.195± 0.854 .204
Executive (z-score) 0.080± 0.702 0.097± 0.744 0.164± 0.722 .035
Speed (z-score) 0.192± 0.664 0.146± 0.688 0.204± 0.667 .36
Medication/APOE ε4
APOE ε4 allele carriers (%) 0.8 1.8 1.7 .28
Medications>5 (number) 35.6 33.9 30.9 .09
*Table represents baseline data. **Chi-square test for categorical variables and analysis of variance (ANOVA) for continuous variables were to test for statis-
tical differences. SD, standard deviation. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; 25OHD, 25 hydroxy-vitamin D;
APOE, apolipoprotein E
test for categorical variables and analysis of variance (ANOVA) for con-
tinuous variables to test for statistical differences.
To calculate longitudinal associations between changes in body
weight and the three domains of cognitive function (Tables 2-4), uni-
variate general linear models (GLMs) were applied controlling for vari-
ous confounders. For each outcome variable the following three-step
model was applied: model 1 adjusted for age, gender, and baseline
cognitive function; model 2 additionally adjusted for 25OHD, base-
line BMI, and PA; and model 3 additionally adjusted for marital sta-
tus, smoking, education,APOE ε4, andmedication use. Results from the
GLMare presented as parameter estimates showing unstandardizedB,
95%CI, and P-value.
To calculate whether changes in body weight predict the onset
of MCI or dementia (Tables 5 and 6), regression analyses were
applied controlling for various confounders as outlined for GLM
above.
The level of statistical significance was set at P< .05.
3 RESULTS
3.1 Baseline
Baseline characteristics of the participants categorized by weight
changes during follow-up can be seen in Table 1. Most of the base-
line characteristics among participants were significantly different
between the three categories. Participants in the weight gain group
had the lowest vitamin D levels, had higher frequency of smoking, and
fewer were married. Participants in the weight gain/loss group had
lower proportion of physical activity.
3.2 Follow-up
During a mean follow-up of 5.2 years, 352 participants (13.4%) lost
weight, 665 (25.3%) gained weight, and 1603 (61.3%) were weight
stable.
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TABLE 2 Associationsa betweenweight-change categories andmemory function among AGES-Reykjavik participants (N= 2620)b
Model 1 Model 2 Model 3
Parameter B 95%CI P B 95%CI P B 95%CI P
Intercept 2.246 1.808 2.685 <.001 2.154 1.647 2.662 <.001 2.105 1.509 2.702 <.001
Weight lossc −0.115 −0.177 −0.054 <.001 −0.114 −0.176 −0.053 <.001 −0.114 −0.176 −0.052 <.001
Weight gainc 0.008 −.070 0.086 .838 0.010 −0.068 0.089 .799 0.016 −0.063 0.094 .696
Baseline of dependent
variable
0.713 0.681 0.745 <.001 0.712 0.680 0.744 .000 0.707 −0.229 −0.109 <.001
Maled −0.147 -0.202 −0.093 <.001 −0.147 −0.203 −0.091 <.001 −0.169 −0.236 −0.117 <.001
Age (years) −0.032 −0.038 −0.026 <.001 −0.032 −0.038 −0.026 <.001 −0.032 −0.038 −0.026 <.001
25OHD (nmol/L) 0.001 −0.001 0.002 .493 0.001 −0.001 0.002 .575
BMI (kg/m2) 0.001 −0.005 0.007 .731 0.001 −0.005 0.008 .718
Physical activity= nonee 0.013 −0.071 0.097 .761 0.022 −0.062 0.107 .604
Physical activity≤3 h/week3 0.038 −0.039 0.114 .331 0.041 −0.035 0.118 .291
Marriedf 0.049 −0.068 0.165 .412
Widowedf 0.032 −0.092 0.155 .613
Divorcedf −0.032 −0.186 0.123 .686
Smoking-nog 0.04 −0.056 0.137 .411
Education- primaryh −0.074 −0.174 0.026 .146
Education-secondaryh −0.065 −0.149 0.018 .125
Education-collegeh −0.075 −0.173 0.022 .128
APOE_ε4 −0.01 −0.219 0.199 .926
Medication use< 5i 0.038 −0.018 0.094 .182
aBased on univariate GLMwith amean 5.2 years of follow-up.
bExcluded: participantswith dementia andmild cognitive impairment at baseline.Model 1: age, gender, and baseline cognitive function.Model 2: additionally
25OHD, bodymass index, and physical activity.Model 3: additionally marital status, smoking, education, apolipoprotein E, andmedication use.
cCompared to weight stable.
dCompared to female.





In these categories 91 (12.6%), 23 (6.2%), and 125 (7.4%) partici-
pants, respectively, were diagnosed with MCI and 42 (5.8%), 30 (8%),
and 64 (3.8%) participants, respectively, were diagnosed with demen-
tia.
Baseline BMI categories (underweight, normal weight, overweight,
obese) were not related to cognitive function or MCI/dementia at the
end of follow-up.
Tables 2–4 show the longitudinal associations between weight
change categories and cognitive function based on GLM. Weight loss
was associated with a lower memory function and lower speed of pro-
cessing after follow-up when compared to weight stable. As shown
in models 1 to 3, correction for baseline cognitive function and BMI,
demographic factors, lifestyle, and medication and APOE ε4 variables
did onlymarginally change these results. However, weight loss was not
associated with executive function.
Tables 5 and 6 show that weight change categories were associated
with the development of MCI and dementia during follow-up based on
logistic regression.Weight loss was associated with a higher likelihood
ofMCIwhen compared toweight stable. Further,weight gainwas asso-
ciated with a higher dementia risk when compared to weight stable.
Similar to the GLM results shown above, the correction for baseline
BMI, demographic factors, and lifestyle aswell asmedication andAPOE
ε4 variables did only marginally change these results.
Inclusion of APOE ε4 and 25OHD as covariates did not change the
results (tables 2-6). Nutritional factors related to vitamin D levels,
that is, cod liver oil consumption and consumption of fatty fish, did
not have significant associations with any of the cognitive function
domains (nutritional resulst (cod liver oil and fatty fish) are not rep-
resented in tables as indicated in text (Not shown in table). However,
results regarding APOE4 and 25 OH D can be seen in tables 2-6.) and
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TABLE 3 Associationsa betweenweight change categories and speed of processing among AGES-Reykjavík participants (N= 2620)a
Model 1 Model 2 Model 3
Parameter B 95%CI P B 95%CI P B 95%CI P
Intercept 1.413 1.049 1.776 <.001 1.506 1.082 1.931 <.001 1.365 0.873 1.856 <.001
Weight lossb −0.116 −0.166 −0.066 <.001 −0.111 −0.161 −0.060 <.001 −0.113 −0.163 −0.062 <.001
Weight gainb −0.036 −0.100 0.028 .272 −0.035 −0.099 0.029 .289 −0.035 −0.099 0.030 .289
Baseline of dependent variable 0.945 0.912 0.977 <.001 0.941 0.908 0.973 <.001 0.930 .894 0.965 <.001
Malec −0.081 −0.124 −0.038 <.001 −0.085 −0.129 −0.041 <.001 −0.098 −0.145 −0.050 <.001
Age (years) −0.022 −0.027 −0.017 <.001 −0.022 −0.027 −0.018 <.001 −0.024 −0.029 −0.018 <.001
25OHD (nmol/L) 0.001 −0.001 0.002 .374 0.001 −0.001 0.002 .45
BMI (kg/m2) −0.003 −0.008 0.002 .219 −0.004 −0.009 0.001 .121
Physical activity= noned −0.009 −0.078 0.059 .790 −0.002 −0.071 0.067 .946
Physical activity≤3 h/week3 0.007 −0.055 0.070 .818 0.008 −0.054 0.071 .794
Marriede 0.036 −0.059 0.131 .456
Widowede 0.034 −0.067 0.134 .514
Divorcede −0.002 −0.128 0.124 .975
Smoking-nof 0.066 −0.013 0.145 .102
Education-primaryg −0.046 −0.129 0.038 .284
Education- secondaryg −0.054 −0.123 0.015 .125
Education- collegeg −0.026 −0.105 0.053 .520
APOE_ε4 0.219 0.049 0.390 .012
Medication use<5h −0.015 −0.061 0.030 .505
aBased on univariate GLM with mean 5.2 years follow-up **Excluded: participants with dementia and mild cognitive impairment at baseline.Model 1: age,
gender, and baseline cognitive function.Model 2: additionally 25OHD, body mass index, and physical activity.Model 3: additionally marital status, smoking,
education, apolipoprotein E,andmedication use.
bCompared to weight stable.
cCompared to female.





therefore did not alter the associations between body weight changes
and cognitive function.
4 DISCUSSION
This large longitudinal study investigated the associations between
body weight changes and cognitive function among community-
dwelling older adults who had normal cognitive function at baseline.
We found that participantswho lostweight during the follow-upperiod
had lower cognitive function after follow-up compared to weight-
stable or weight-gaining participants. We also found that these par-
ticipants had a higher risk of developing MCI. Furthermore, our study
suggests that participants who gainedweight during follow-up were at
an increased risk for dementia compared toweight-stable participants.
BMI categories themselves were neither related to cognitive function
nor to risk ofMCI or dementia.
Because the risk of reverse causation can distort the relation-
ship between dementia and weight loss, the current study exclusively
included participants with normal cognitive function at baseline, which
reduces this risk. The associations between body weight changes and
cognitive functionwe found agreewith several previous studies on this
topic.1–6 When comparing results from different studies, it has to be
considered that longitudinal studies concerning bodyweight, BMI, and
cognitive function use various techniques measuring cognitive abili-
ties with different endpoints ranging from MCI to dementia. In addi-
tion, studies enroll participants of different age groups and it has been
shown that, for example, high BMI can be both detrimental as well as
protective for a given health outcome depending on the participant’s
age.31–33
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TABLE 4 Associationsa betweenweight change categories and executive function among AGES-Reykjavík participants (N= 2620)a
Model 1 Model 2 Model 3
Parameter B 95%CI P B 95%CI P B 95%CI P
Intercept 0.790 0.378 1.202 <.001 0.917 0.436 1.398 <.001 1.144 0.583 1.706 <.001
Weight lossb −0.030 −0.089 0.028 .311 −0.024 −0.083 0.035 .417−0.029 −0.088 0.030 .336
Weight gainb −0.029 −0.104 0.045 .444 −0.028 -0.103 0.047 .458−0.025 −0.099 0.050 .521
Baseline of dependent variable 0.660 0.625 .694 <.001 0.656 0.622 0.691 <.001 0.632 0.596 0.668 <.001
Malec −0.105 −0.155 −0.055 <.001 −0.108 −0.159 −0.057 <0.001−0.135 −0.189 −0.080 <.001
Age (years) −0.013 −0.019 −0.008 <.001 −0.013 −0.018 −0.007 <0.001−0.013 −0.019 −0.008 <.001
25OHD (nmol/L) 0.000 −0.001 0.002 0.571 0.000 −0.001 0.002 .753
BMI (kg/m2) −0.004 −0.010 0.002 0.161−0.004 −0.010 0.003 .257
Physical activity= noned −0.022 −0.102 0.058 0.586−0.003 −0.083 0.077 .941
Physical activity≤3 h/wk3 0.018 −0.055 0.091 0.634 0.023 −0.049 0.096 .527
Marriede −0.024 −0.134 0.087 .676
Widowede −0.003 −0.120 0.114 .957
Divorcede −0.049 −0.196 0.097 .509
Smoking-nof 0.075 −0.017 0.166 .109
Education-primaryg −0.218 −0.314 −0.122 <.001
Education-secondaryg −0.139 −0.219 −0.059 .001
Education- collegeg −0.092 −0.184 0.001 .051
APOE_ε4 −0.138 −0.336 0.061 .175
Medication use<5h 0.038 −0.015 0.090 .165
aBased on univariate GLM with mean 5.2-years follow-up. **Excluded: participants with dementia and mild cognitive impairment at baseline.Model 1: age,
gender, and baseline cognitive function.Model 2: additionally 25OHD, body mass index, and physical activity.Model 3: additionally marital status, smoking,
education, apolipoprotein E, andmedication use.
bCompared to weight stable.
cCompared to female.





In the present study, weight loss was associated with faster cogni-
tive decline for memory and speed of processing when compared to
weight-stable or weight-gaining participants. Of interest, intentional
weight loss in obese/overweight adults has been reported to be asso-
ciated with improvements in performance across various cognitive
domains,34 which might further be related to significant reduction in
metabolic syndrome.35 However, in a recently published cohort study
among community-dwelling older adults, weight loss predicted higher
cognitive decline over a 5-year follow-up, independently of baseline
BMI.36
Furthermore, it has been reported that both weight loss and weight
gain were associated with poor cognitive performance in middle-aged
and older women compared with women with stable weight after
7 years of follow-up.37
In our study,weight loss during the studyperiodwas associatedwith
a 61% higher risk of MCI diagnosis. This is in agreement with a large
prospective longitudinal cohort study from the United States in which
weight loss was associated with a higher risk of incident MCI indepen-
dent from BMI.38 Similar results were reported in old adults from an
African study with 10 years of follow-up.39
Contrary to our expectations, we found that weight gain during
follow-up was associated with a greatly increased risk of dementia. In
contrast, two cohort studies from the United States reported weight
loss to be associated with a higher risk of incident dementia,36,40
whereas weight gain did not have any significant associations.36 No
information is available in published literature linking weight gain
with dementia risk, although there are several studies published
having linked obesity to dementia risk.41,42 However, according to a
recent meta-analysis, current available evidence does not support an
association between overweight/obesity and incident dementia in old
age.10 There are many studies available that link BMI categories with
cognitive function, MCI, and dementia.33,43,44 In the present study,
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TABLE 5 Bodyweight change categories and risk of development ofMCI among AGES-Reykjavik participants (N= 2620)a
Model 1 Model 2 Model 3
Parameter OR 95%CI P OR 95%CI P OR 95%CI P
Weight lossb 1.590 1.141 2.216 .006 1.526 1.092 2.133 .013 1.613 1.145 2.271 .006
Weight gainb 1.048 0.633 1.736 .855 1.004 0.605 1.667 .987 0.951 0.566 1.597 .849
Malec 0.663 0.489 0.900 .008 0.626 0.459 0.855 .003 0.449 0.319 0.632 <.001
Age (years) 1.142 1.106 1.178 <.001 1.143 1.106 1.179 <.001 1.137 1.097 1.177 <.001
25OHD (nmol/L) 0.990 0.981 1.000 .042 0.992 0.983 1.001 .097
BMI (kg/m2) 1.009 0.972 1.048 .636 1.000 0.961 1.040 .994
Physical activity= noned 1.194 0.723 1.972 .485 1.027 0.613 1.721 .920
Physical activity≤3 h/wk3 1.051 0.654 1.689 .838 1.017 0.625 1.654 .946
Marriede 1.227 0.565 2.665 .606
Widowede 1.464 0.661 3.242 .347
Divorcede 1.862 0.724 4.790 .197
Smoking-nof 0.660 0.385 1.129 .129
Education-primaryg 8.499 3.729 19.373 <.001
Education-secondaryg 4.719 2.133 10.438 <.001
Education-collegeg 1.909 0.762 4.780 .167
APOE_ε4 0.776 0.228 2.641 .685
Medication use<5h 0.688 0.502 0.945 .021
aBased on logistic regression with mean 5.2 years follow-up. **Excluded: participants with dementia andmild cognitive impairment at baseline.Model 1: age,
gender, and baseline cognitive function.Model 2: additionally 25OHD, body mass index, and physical activity.Model 3: additionally marital status, smoking,
education, apolipoprotein E, andmedication use.
bCompared to weight stable.
cCompared to female.






BMI categorieswere not related to cognitive decline,MCI, or dementia
diagnosis. It has to be considered that of our study population, actually
few were underweight (n = 22), which excludes the possibility of a
meaningful statistical analysis. On the other hand, our study shows
that body weight change is an important predictor of future cognitive
function independent of BMI category.
There are several plausible explanations as to how body weight
changes can be associated with cognitive function. However, they fail
to explain our findings entirely because body weight stability has been
associated with an intact social environment and might in general
reflect good health in an older adult. Weight loss on the other hand
mightbeanearly signofdeterioratinghealth.Althoughbody fat is asso-
ciated with increased levels of leptin,45 which might act as protective
factor for cognition in old age,46 weight gain in older adulthood can also
be associated with sedentary lifestyle and physical inactivity.
In fact, the distribution of body fat might be crucial to understand
the inconclusive associations between obesity and dementia.47 In the
present study, we cannot distinguish between visceral and subcuta-
neous fat in the weight gain group, but previous studies have shown
an association between visceral adipose tissue (rather than subcuta-
neous adipose tissue) andmicrostructural brain tissue damages as well
as poorer brain connectivity.47,48 In this perspective it is appropriate
to discuss a study by Spauwen et al. (2017), which is a cross-sectional
study using data from AGES-Reykjavik, showing that a higher amount
of subcutaneous fat was negatively associated with the risk of demen-
tia at baseline.49 Thus visceral fatmight be adriving force in these asso-
ciations betweenweight gain and dementia.
Previous studies have shown that type 2 diabetes increases the risk
of dementia21, therefore, we considered type 2 diabetes in additional
analyses. Our results showed that the association between weight
changes and cognitive function/MCI/dementia was unchanged when
controlling for type 2 diabetes.
Physical activity has been shown to have positive implications for
various health-related outcomes among older adults,50–52 including
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TABLE 6 Bodyweight change categories and risk of development of dementia among AGES-Reykjavik participants (N= 2620)a
Model 1 Model 2 Model 3
Parameter OR 95%CI P OR 95%CI P OR 95%CI P
Weight lossb 1.094 0.625 1.915 .752 1.028 0.584 1.810 .911 1.076 0.607 1.909 .802
Weight gainb 2.797 1.585 4.935 <.001 2.663 1.504 4.716 <.001 2.697 1.511 4.815 .001
Malec 0.996 0.622 1.593 .986 0.945 0.586 1.525 .818 0.787 0.468 1.322 .366
Age (years) 1.183 1.129 1.239 <.001 1.181 1.126 1.237 <.001 1.182 1.124 1.244 <.001
25OHD (nmol/L) 0.990 0.977 1.004 .165 0.991 0.977 1.005 .203
BMI (kg/m2) 0.997 0.943 1.055 .924 0.993 0.937 1.053 .814
Physical activity= noned 1.420 0.654 3.084 .376 1.245 0.564 2.748 .588
Physical activity≤3 h/wk3 0.996 0.468 2.120 .991 0.995 0.463 2.139 .989
Marriede 0.537 0.245 1.177 .120
Widowede 0.399 .0171 0.927 .033
Divorcede 0.308 0.078 1.214 .092
Smoking-nof 0.769 0.332 1.784 .541
Education- primaryg 5.188 1.726 15.593 .003
Education-secondaryg 2.405 0.824 7.016 .108
Education-collegeg 2.459 0.783 7.723 .123
APOE_ε4 0.564 0.124 2.577 .460
Medication use<5h 0.933 0.573 1.518 .780
aBased on logistic regressionwithmean 5.2-years follow-up. **Excluded: participants with dementia andmild cognitive impairment at baseline.Model 1: age,
gender, and baseline cognitive function.Model 2: additionally 25OHD, body mass index, and physical activity.Model 3: additionally marital status. smoking,
education, apolipoprotein E, andmedication use.
bCompared to weight stable.
cCompared to female.




hCompared tomedication use≥5. OR, odds ratio.
brain health.4,53 As shown in Table 1, the proportion of physical inactiv-
ity among the weight gain group was high, or 31%. Additional calcula-
tions (not shown in table) stratifying by physical activity levels showed
that the weight gain associations were driven mainly by participants
whodidnot engage in anyphysical activity.Weight-gainingparticipants
reporting no participation in physical activity had a 3.8 higher odds for
dementia compared to weight stable participants (odds ratio [OR]: 3.8,
P= .03). This further confirms the protective effects of physical activity
among this group of older adults.
This study has limitations, since it cannot explain what contributes
to the weight loss of the older adult, weather it is voluntary or invol-
untary. We suggest that losing weight because of inadequate caloric
intake or as a part of disease progression might be the negative fac-
tor in these associations. Future intervention studies should address
the question ofwhether keeping bodyweight stable during older adult-
hood helps to maintain cognitive function and decreases risk of MCI
and dementia.
In addition, because dementia is a hyper term, representing a broad
array of brain diseases, we could not distinguish between common sub-
groups like AD and vascular dementia, thereby limiting precise inter-
pretation of weight changes among older adults.
It is a strength of our longitudinal study that it included a large num-
ber of participants who underwent detailed examinations at baseline
and at follow-up of the study.
In thepresent statistical analyses,we included several potential con-
founders. The extensive statistical correction only marginally changed
results in the GLM and logistic regressionmodels. Unexpectedly, phys-
ical activity and nutritional factors were not significantly associated
with any of the cognitive function domains or risk of dementia/MCI
diagnosis in the final analysis and therefore did not confound the
observed associations between body weight changes and cognitive
function. Furthermore, APOE ε4, although being significantly related to
cognitive function in our study, did not change the observed associa-
tions between bodyweight change and cognitive outcomes.
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5 CONCLUSION
Our study showed that participants who lost body weight during
the follow-up period had lower cognitive function after follow-up
compared to weight-stable or weight-gaining participants, and con-
sequently these participants had a higher risk of developing MCI. In
contrast to our expectations, we found that participants who gained
weight during follow-up were at an increased risk for dementia com-
pared to weight-stable participants. Level of BMI categories them-
selves were neither related to cognitive function nor to risk of MCI or
dementia.
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